Single-Stranded Hairpin Loop RNAs (loopmeRNAs) Potently Induce Gene Silencing through the RNA Interference Pathway

Area of Science:

• Biochemistry
• Molecular Biology
• RNA Therapeutics

Background:

• Small interfering RNAs (siRNAs) conjugated to N-acetylgalactosamine (GalNAc) are clinically approved for liver disease treatment.
• Chemical modifications like phosphorothioate linkages and ribose modifications are crucial for siRNA stability, potency, and duration.
• Alternative RNA designs (Dicer-substrate RNA, shRNA, circular RNA) show promise but face challenges in incorporating essential chemical modifications for clinical use.

Purpose of the Study:

• To develop a facile synthesis method for GalNAc-conjugated single-stranded loop hairpin RNAs (loopmeRNAs) that allows for straightforward incorporation of chemical modifications.
• To evaluate the in vivo efficiency and optimize the structure-activity relationship of novel loopmeRNA designs.
• To demonstrate that loopmeRNAs can achieve gene silencing efficacy comparable to conventional siRNAs with reduced environmental and regulatory impact.

Main Methods:

• Synthesis of GalNAc-ligand-containing single-stranded loop hairpin RNAs (loopmeRNAs) with clinically relevant chemical modifications.
• In vivo evaluation of loopmeRNA efficiency in silencing target gene expression.
• In vitro metabolism studies to support structure-activity relationship analysis.
• Optimization of loop region sequences and chemical modifications for maximal potency.

Main Results:

• A facile synthesis of loopmeRNAs incorporating clinically relevant chemical modifications was achieved.
• LoopmeRNAs demonstrated efficient gene silencing in vivo with efficacy comparable to conventional double-stranded siRNAs.
• Structure-activity relationship studies, supported by in vitro metabolism data, guided the optimization of loopmeRNA designs for maximal potency.

Conclusions:

• LoopmeRNAs represent a promising alternative RNA therapeutic design that allows for straightforward synthesis and incorporation of chemical modifications.
• These novel RNA molecules offer comparable gene silencing efficacy to traditional siRNAs.
• LoopmeRNAs present reduced environmental and regulatory burdens, potentially advancing the field of RNA therapeutics for liver diseases.